7 results about "Health screening" patented technology

This invention discloses a method and system for perioperative follow-up management of renal biopsy, relating to the fields of medical information processing and health screening technology. It acquires basic patient information, symptom information, and test report images; performs layout parsing and field recognition on the test reports to generate structured indicator data; performs discrete coding, interval mapping, and classification labeling on multi-source data to construct a set of indicator units; identifies major risk sources through type-based grouping and normalization, threshold screening based on contribution values, and sorting; calculates the total risk score and determines the risk level, generating risk labels; dynamically adjusts monitoring items, behavioral constraints, and medication management content based on risk labels to form an individualized postoperative management plan; simultaneously generates follow-up time nodes based on risk levels and executes reminder scheduling; and combines doctor-patient interaction records to achieve follow-up status tracking and data statistical analysis. This invention achieves closed-loop processing of perioperative risk assessment and follow-up management.

This application relates to the field of medical data processing, proposing a medical data processing method, related apparatus, and storage medium. The method includes: acquiring electronic health records, genomic data, family medical history, lifestyle and behavioral data, and environmental exposure data of a target user within a preset time window; determining the target user's temporal characteristics, static baseline characteristics, and interaction characteristics; predicting the risk value of the target user for a target disease in multiple future time periods; determining the risk gradient value of the target user for the target disease in each future time period; and determining a health screening strategy for the target disease based on the risk value and risk gradient value of the target disease in multiple future time periods. This application predicts the future risk value and risk gradient value of the target disease using multimodal data of the target user, and formulates targeted health screening strategies, fully considering individual differences. The formulated health screening strategies are more tailored to each individual's actual situation.

The application relates to the technical field of AI large models, and discloses a health information management method and system based on an AI large model, which comprises the following steps: performing feature fusion coding on health screening information collected by a health screening device to obtain a fusion feature vector; performing health portrait coding through an AI large model to obtain a user health portrait vector and perform clustering and typing to obtain a crowd typing category; screening candidate health products through a conditioning product matching score model based on the user health portrait vector and the crowd typing category to obtain a health product recommendation list; and generating a physiotherapy conditioning scheme configuration package based on the user health portrait vector and issuing the physiotherapy conditioning scheme configuration package to surrounding physiotherapy equipment to complete remote presetting. The application solves the problem that traditional Chinese medicine diagnosis data and western medicine physiological indexes cannot be jointly modeled in the prior art, and makes the health portrait capable of comprehensively reflecting the comprehensive health status of a user.

This utility model relates to the field of medical and health technology, specifically to a portable population health screening and risk assessment device, including a telescopic stool and a joint component. The telescopic stool is fixedly connected to a strap, and the joint component is fixedly connected to the strap. The joint component includes an angle plate, one end of which is rotatably connected to a first support frame, and the other end of which is rotatably connected to a second support frame. Both the first and second support frames are fixedly connected to a telescopic strap. This utility model is used to accurately and clearly record the angle values ​​of the knee joint in different states during the screening process, thereby assessing whether the subject's knee joint has any damage.

The present application belongs to the technical field of blood safety management, and particularly relates to a tracing method, system, terminal and storage medium for blood management. The tracing method for blood management comprises the following steps: obtaining the identity information of a blood entry person and performing health screening verification to generate a health verification result; performing blood sampling treatment on the entry person according to the health verification result, and constructing blood information data; collecting view information of a blood sampling operation process by a blood transport box to generate a collection verification result, so as to determine the storage permission of the blood collection container; controlling the transport temperature in the blood transport box according to the environmental information and the blood information data; and checking information and entering a related management system before warehousing. The present application can improve the management efficiency.

This invention provides a combination of serum biomarkers for the diagnosis of gastric cancer and their applications. This invention is the first to discover that CHI3L1, FCGBP, TFF2, and VSIG2 are significantly elevated in the serum of gastric cancer patients. ROC curve analysis verified that the combination of these four proteins as serum biomarkers can effectively distinguish between gastric cancer patients and healthy controls, and that combined use can better differentiate between early and late-stage gastric cancer patients, demonstrating superior diagnostic value for gastric cancer. Compared with traditional methods for gastric cancer diagnosis, the serum biomarker combination established in this invention is non-invasive, improving the accuracy of gastric cancer diagnosis. It can be used as a health screening test and provides an efficient and non-invasive detection method for gastric cancer patients who cannot undergo pathological examination.